Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.

Míreanna comhchosúla

• Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
  de réir: Mele, T, et al.
  Foilsithe / Cruthaithe: (2010)
• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
  de réir: Fox, S, et al.
  Foilsithe / Cruthaithe: (2011)
• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
  de réir: Fox, S, et al.
  Foilsithe / Cruthaithe: (2011)
• Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
  de réir: Generali, D, et al.
  Foilsithe / Cruthaithe: (2009)
• Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
  de réir: Generali, D, et al.
  Foilsithe / Cruthaithe: (2009)